Arcutis Biotherapeutics Inc — Financial Statements (NASDAQ:ARQT) | MetaTrader

Open full chart

ニュース

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham、好調な売上を受けてArcutis株の目標株価を36ドルに引き上げ

Needham raises Arcutis stock price target to $36 on strong sales

H.C. Wainwright、Zoryveの好調な売上を受けてArcutis株の目標株価を引き上げ

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis 2025年第4四半期決算：ZORYVEが収益性を牽引、売上高は予想を上回る

Arcutis Q4 2025 slides: ZORYVE drives profitability, revenue beats

Dow Jones Futures Fall Despite Strong Nvidia Earnings After S&P 500 Reclaims Key Level

Arcutis earnings beat by $0.05, revenue topped estimates